Skip to main content
. 2011 Apr 5;84(4):551–555. doi: 10.4269/ajtmh.2011.10-0423

Table 1.

Clinical characteristics, prevalence of helminths, and outcome of cutaneous leishmaniasis (CL) patients*

Early treatment group (N = 45) Control group (N = 45) P value
Male (%) 34/45 (75.6%) 32/45 (71.1%) 0.64
Age, mean in years ± SD 25.7 ± 10.0 25.5 ± 9.8 0.93
BMI, median in kg/m2 (IQR) 21.3 (19.4–24.7) 22.3 (20.7–24.0) 0.67§
No. (%) with 1 lesion 34 (75.6%) 34 (75.6%)
No. (%) with 2 lesions 7 (16.7%) 8 (17.8%)
No. (%) with 3 lesions 4 (8.9%) 3 (6.7%)
Lesion size, median (IQR), mm2 180 (70–400) 198 (100–400) 0.78§
No (%) helminth
Mean egg count/gm stool (range)
Hookworm 43/45 (95.6%) 38/45 (84.4%) 0.079
400 [24–1920] 423 [24–2332]
Trichiura trichuris 30/45 (66.7%) 15/45 (33.3%) 0.0016
324 [24–840] 361 [24–2424]
Ascaris lumbricoides 31/45 (68.9%) 25/45 (55.6%) 0.019
9786 [24–42,428] 10,803 [24–48,404]
Strongyloides stercoralis 2/45 (4.4%) 3/45 (6.7%) 1.00
Schistosoma mansoni 6/45 (13.3%) 7/45 (15.6%) 0.76
276 [24–768] 124 [24–288]
Time to cure, median (IQR), days 98 (64–138) 88 (56–126) 0.13**
*

BMI = body mass index; IQR = interquartile range; SD = standard deviation.

χ2 test.

Student's t test.

§

Wilcoxon rank-sum test.

The lesion with the greatest area at presentation was considered to be the main lesion.

Fisher's exact test.

**

Log-rank test.